openPR Logo
Press release

SMi’s Europe’s Leading Ophthalmic Conference is only 2 weeks away!

11-15-2017 12:23 PM CET | Science & Education

Press release from: SMi Group

SMi’s Europe’s Leading Ophthalmic Conference is only 2

QUICK UPDATE: SMi’s Ophthalmic Drugs will be taking place in JUST 2 WEEKS at the Copthorne Tara Hotel in London, Kensington UK. Network with top pharma companies are joining us including Boehringer Ingelheim, Bayer, Envisia Therapeutics, NightstaRx, Shire, Novaliq GmbH and more. www.ophthalmicdrugs.com/opr

[NEW ATTENDEES] - Fresenius Kabi | Nanoptima | Nicox

[NEW SPEAKER] - We are delighted to welcome Sunil Shah, Professor/Director, Midland Eye Centre onto the programme!

With a global presence, this year's event will feature an exceptional line-up of keynote speakers from industry leading organisations. Ophthalmic Drugs arrives at the perfect time to discuss the latest approaches and strategies in key areas such as ocular diseases, drug delivery, pre-clinical and clinical trials, computer technologies and therapies for diabetic macular oedema.

Learn About:

- The unmet needs and management of presbyopia
- Processes and development of gene delivery technology for ocular drugs
- Clinical endpoints being explored now and in the future
- The application of emerging technologies
- The evolution of treatment options for patients with DMO
- Controlled trials of Lifitegrast and clinical results
- Non-invasive therapies for diabetic macular oedema
- The negative side effects of preservatives

Further information is available at: www.ophthalmicdrugs.com/opr

For those looking to attend there are currently special rates available. Book online or get in touch.

SMi Presents the Launch of…

Ophthalmic Drugs
Date: 28th – 29th November 2017
Location: Kensington, London
Website: www.ophthalmicdrugs.com/opr

Sponsored by: Leica Microsystems | Experimentica

---end---

Contact Information:

For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Westminster Bridge Road
1

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release SMi’s Europe’s Leading Ophthalmic Conference is only 2 weeks away! here

News-ID: 818252 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Ophthalmic

Prominent Ophthalmic Knives Market Trend for 2025: Innovative Developments In Op …
Which drivers are expected to have the greatest impact on the over the ophthalmic knives market's growth? The increasing prevalence of eye-related conditions is expected to boost the ophthalmic knives market. Conditions such as cataracts, glaucoma, and diabetic retinopathy are rising due to aging populations and lifestyle changes. Ophthalmic knives are used in surgeries to treat these conditions, helping to improve vision and manage eye health. The CDC's January 2024 report
Ophthalmic Devices Market
According to the report, the global ophthalmic devices market garnered $32.53 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.0% from 2020 to 2027. Drivers, restraints, and opportunities- Increase in adoption of digital devices in health care sector and technological advancement in the ophthalmic devices drive the growth of the global ophthalmic devices market. However, lack of sled professional and low awareness regarding eye-related
Ophthalmic Packaging Market Report 2024 - Ophthalmic Packaging Market Trends And …
"The Business Research Company recently released a comprehensive report on the Global Ophthalmic Packaging Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Ophthalmic Lasers Market - Empowering Progress, Shaping Eye Care Excellence: Rev …
Newark, New Castle, USA - new report, titled Ophthalmic Lasers Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Ophthalmic Lasers market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Ophthalmic Lasers market. The report offers an overview of the market, which
Ophthalmic Eye Shield Market Segmentation By Material type Aluminium Ophthalmic …
Eye shields are advised for use in the eye while a periorbital surgery to avoid any injury to the globe. Ophthalmic eye shields are used for postoperative ocular protection. Ophthalmic eye shields protect the cornea and retina while any eye surgery or laser treatment. Ophthalmic eye shields are highly preferred for cataract surgeries in the elder population and blepharitis correction especially for children. According to WHO, The World Health Organization,
Ophthalmic Lasers Market: Demand for Ophthalmic Lasers to Remain Higher in North …
Lasers have become an essential part of treatment modality for a number of practicing ophthalmologist. Ophthalmic lasers have gained prominence with the popularity of laser-assisted surgeries for rectifying nearsightedness or myopia. The increasing incidence of ophthalmic disorders and rise in geriatric population in various regions have boosted the application of different types of lasers in treating specific eye problems and improving vision. Technological advances have significantly increased the safety and